Clinical Trial Update: Sphingolipids in Asthma Pathogenesis

View source ↗

Summary

A clinical trial update from Peking University Third Hospital indicates a study on sphingolipids in asthma pathogenesis, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Peking University Third Hospital | Conditions: Asthma | Status: NOT_YET_RECRUITING